îæ€çŽ¢
îæ€çŽ¢
î
Senti Biosciences Inc
SNTIîãŠã©ãããªã¹ãã«è¿œå
0.341USD
-0.020-5.52%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
10.60Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Thu, May 14
æŽæ°æå»: Thu, May 14
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Celadon Partners SPV 24
31.39%
New Enterprise Associates (NEA)
12.12%
Bayer HealthCare LLC
9.02%
PharmaEssentia Corp.
6.78%
Nantahala Capital Management, LLC
2.85%
ä»ã®
37.83%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Celadon Partners SPV 24
31.39%
New Enterprise Associates (NEA)
12.12%
Bayer HealthCare LLC
9.02%
PharmaEssentia Corp.
6.78%
Nantahala Capital Management, LLC
2.85%
ä»ã®
37.83%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
47.19%
Venture Capital
12.24%
Hedge Fund
2.86%
Investment Advisor
2.54%
Investment Advisor/Hedge Fund
0.56%
Individual Investor
0.40%
Research Firm
0.27%
ä»ã®
33.94%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
44
6.38M
20.48%
-844.92K
2025Q4
42
5.88M
22.37%
-1.23M
2025Q3
48
7.00M
26.75%
-1.06M
2025Q2
59
22.40M
85.87%
+17.02M
2025Q1
61
32.06M
123.04%
+28.81M
2024Q4
55
2.74M
57.01%
+442.53K
2024Q3
56
2.03M
44.31%
-591.63K
2024Q2
59
2.00M
43.68%
-736.88K
2024Q1
91
2.11M
47.03%
-1.57M
2023Q4
97
2.11M
47.62%
-1.61M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Celadon Partners SPV 24
9.78M
31.39%
--
--
Jan 19, 2026
New Enterprise Associates (NEA)
3.78M
12.12%
--
--
Mar 27, 2026
Bayer HealthCare LLC
2.81M
9.02%
+2.22M
+377.99%
Mar 10, 2025
PharmaEssentia Corp.
2.11M
6.78%
--
--
Apr 28, 2025
Nantahala Capital Management, LLC
888.00K
2.85%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
144.80K
0.46%
-8.04K
-5.26%
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
132.37K
0.42%
+132.37K
--
Dec 31, 2025
Lu (Timothy K M.D., Ph.D.)
76.77K
0.25%
-80.67K
-51.24%
Mar 09, 2026
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Tue, Dec 2
æŽæ°æå»: Tue, Dec 2
éæå
æ¯ç
iShares Micro-Cap ETF
0%
ARK Genomic Revolution ETF
0%
iShares Micro-Cap ETF
æ¯ç0%
ARK Genomic Revolution ETF
æ¯ç0%